69 related articles for article (PubMed ID: 16513623)
1. Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
van Eerd JE; Vegt E; Wetzels JF; Russel FG; Masereeuw R; Corstens FH; Oyen WJ; Boerman OC
J Nucl Med; 2006 Mar; 47(3):528-33. PubMed ID: 16513623
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles.
Stangl S; Nguyen NT; Brosch-Lenz J; Šimeček J; Weber WA; Kossatz S; Notni J
Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38717591
[TBL] [Abstract][Full Text] [Related]
3. Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: a meta-analysis.
Saw MM; Chandler B; Ho KM
Anaesth Intensive Care; 2012 Jan; 40(1):17-32. PubMed ID: 22313061
[TBL] [Abstract][Full Text] [Related]
4. Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands.
de Roode KE; Joosten L; Behe M
Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399470
[TBL] [Abstract][Full Text] [Related]
5. First preclinical evaluation of [
Handula M; Beekman S; Konijnenberg M; Stuurman D; de Ridder C; Bruchertseifer F; Morgenstern A; Denkova A; de Blois E; Seimbille Y
EJNMMI Radiopharm Chem; 2023 Jun; 8(1):13. PubMed ID: 37389800
[TBL] [Abstract][Full Text] [Related]
6. New Radiolabeled Exendin Analogues Show Reduced Renal Retention.
Joosten L; Frielink C; Jansen TJP; Lobeek D; Andreae F; Konijnenberg M; Heskamp S; Gotthardt M; Brom M
Mol Pharm; 2023 Jul; 20(7):3519-3528. PubMed ID: 37265006
[TBL] [Abstract][Full Text] [Related]
7. New Long-Acting [
Wilbs J; Raavé R; Boswinkel M; Glendorf T; Rodríguez D; Fernandes EFA; Heskamp S; Bjørnsdottir I; Gustafsson MBF
J Med Chem; 2023 Jun; 66(12):7772-7784. PubMed ID: 36995126
[TBL] [Abstract][Full Text] [Related]
8. Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies.
Lau J; Lee H; Rousseau J; Bénard F; Lin KS
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956909
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological agents for the prevention of colistin-induced nephrotoxicity.
Mirjalili M; Mirzaei E; Vazin A
Eur J Med Res; 2022 May; 27(1):64. PubMed ID: 35525994
[TBL] [Abstract][Full Text] [Related]
10. Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model.
Ertveldt T; De Beck L; De Ridder K; Locy H; de Mey W; Goyvaerts C; Lecocq Q; Ceuppens H; De Vlaeminck Y; Awad RM; Keyaerts M; Devoogdt N; D'Huyvetter M; Breckpot K; Krasniqi A
Mol Cancer Ther; 2022 Jul; 21(7):1136-1148. PubMed ID: 35499391
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the PSMA-Binding Ligand
Stenberg VY; Larsen RH; Ma LW; Peng Q; Juzenas P; Bruland ØS; Juzeniene A
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062920
[TBL] [Abstract][Full Text] [Related]
12. Nanobodies for Medical Imaging: About Ready for Prime Time?
Berland L; Kim L; Abousaway O; Mines A; Mishra S; Clark L; Hofman P; Rashidian M
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925941
[TBL] [Abstract][Full Text] [Related]
13. HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.
Altunay B; Morgenroth A; Beheshti M; Vogg A; Wong NCL; Ting HH; Biersack HJ; Stickeler E; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1371-1389. PubMed ID: 33179151
[TBL] [Abstract][Full Text] [Related]
14.
Zettlitz KA; Tavaré R; Tsai WK; Yamada RE; Ha NS; Collins J; van Dam RM; Timmerman JM; Wu AM
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):489-500. PubMed ID: 30456475
[TBL] [Abstract][Full Text] [Related]
15. Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway.
Cen B; Liao W; Wang Z; Gao L; Wei Y; Huang W; He S; Wang W; Liu X; Pan X; Ji A
Mol Ther Nucleic Acids; 2018 Jun; 11():300-311. PubMed ID: 29858065
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Gelofusine against cRGD-siRNA-induced nephrotoxicity in mice.
Liao W; Qin Y; Liao L; Cen B; Wu Z; Wei Y; Wang Z; Li G; Ji A
Ren Fail; 2018 Nov; 40(1):187-195. PubMed ID: 29619875
[TBL] [Abstract][Full Text] [Related]
17. Gelofusine Ameliorates Colistin-Induced Nephrotoxicity.
Sivanesan SS; Azad MAK; Schneider EK; Ahmed MU; Huang J; Wang J; Li J; Nation RL; Velkov T
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923868
[TBL] [Abstract][Full Text] [Related]
18. Renal Handling of Circulating and Renal-Synthesized Hepcidin and Its Protective Effects against Hemoglobin-Mediated Kidney Injury.
van Swelm RP; Wetzels JF; Verweij VG; Laarakkers CM; Pertijs JC; van der Wijst J; Thévenod F; Masereeuw R; Swinkels DW
J Am Soc Nephrol; 2016 Sep; 27(9):2720-32. PubMed ID: 26825531
[TBL] [Abstract][Full Text] [Related]
19. The influence of stabilizers on the production of gold nanoparticles by direct current atmospheric pressure glow microdischarge generated in contact with liquid flowing cathode.
Dzimitrowicz A; Jamroz P; Greda K; Nowak P; Nyk M; Pohl P
J Nanopart Res; 2015; 17(4):185. PubMed ID: 25960686
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
D'Huyvetter M; Xavier C; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Expert Opin Drug Deliv; 2014 Dec; 11(12):1939-54. PubMed ID: 25035968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
